Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Monsanto (Idanha-a-Nova) the ammunition depot of the castle. The mountain rock is granite, which also the historic and present village is built upon in a fusion of nature and its landforms. This fusion can be seen in the uses of caves and rocks being converted into construction parts. Monsanto (Idanha-a-Nova) Monsanto is a village and a former civil parish in the municipality of Idanha-a-Nova, Portugal. In 2013, the parish merged into the new parish Monsanto e Idanha-a-Velha. It covered an area of 131.76 km² and had 828 inhabitants (June 30, 2011). It was the principal town of the "concelho" between 1174 and